Cryoablation Devices Market Report 2025

This Cryoablation Devices market report provides a comprehensive analysis of the market’s characteristics, size, and growth, including segmentation, regional and country-level breakdowns, competitive landscape, market shares, trends, and strategies. It also tracks historical and forecasted market growth across various geographies.

The cryoablation devices market size has grown rapidly in recent years. It will grow from $0.56 billion in 2024 to $0.62 billion in 2025 at a compound annual growth rate (CAGR) of 10.8%. The growth in the historic period can be attributed to increased funding and grants from government agencies, expansion of cryoablation training and education, the rise of outpatient and ambulatory surgery centers, rise in hybrid treatment approaches, and growth in outpatient procedures.

The cryoablation devices market size is expected to see rapid growth in the next few years. It will grow to $0.92 billion in 2029 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period can be attributed to the increasing prevalence of cancer, rising cases of cardiovascular diseases, increasing number of clinical trials, rising geriatric population, and increasing consumption of tobacco and alcohol. Major trends in the forecast period include technological advancements, portable cryoablation devices, nanotechnology integration, hybrid procedures, and artificial intelligence.

The growing prevalence of cardiovascular diseases is expected to drive the expansion of the cryoablation devices market in the coming years. Cardiovascular diseases (CVD) include a range of heart and blood vessel disorders, such as coronary artery disease, hypertension, heart failure, arrhythmias, and stroke. The rise in CVD cases is attributed to factors like aging populations, increasing obesity rates, and greater exposure to risk factors like smoking and pollution. Cryoablation devices are essential in cardiology for treating arrhythmias, such as atrial fibrillation, by creating controlled lesions in heart tissue to disrupt abnormal electrical pathways, helping restore normal heart rhythm and enhancing patient quality of life. For example, in June 2024, the Australian Institute of Health and Welfare, a government agency based in Australia, reported that doctor-certified deaths from coronary heart disease (CHD) rose from 14,100 in 2021 to 14,900 in 2022. As such, the rising prevalence of cardiovascular diseases is expected to fuel the growth of the cryoablation devices market.

Leading companies in the cryoablation devices market are concentrating on the development of innovative products, such as cryoprobes, to improve the precision and effectiveness of treatments. A cryoprobe is a medical instrument used in cryotherapy, a procedure that applies extreme cold to tissue in order to treat conditions like tumors, lesions, or abnormal growths. For example, in May 2023, Varian, a U.S.-based medical device company and part of Siemens Healthineers, launched the Isolis cryoprobe. The Isolis cryoprobe is a single-use, disposable device designed to enhance precision and efficiency in cryoablation procedures, where tissue is carefully frozen to address conditions like tumors. It provides interventional radiologists with improved control through its sharp tip and optional integration with the Siemens Healthineers myNeedle Laser guidance system for precise probe placement.

In August 2022, Medtronic plc, an Ireland-based provider of medical supplies, acquired Affera Inc. for an undisclosed amount. This acquisition is aimed at strengthening Medtronic's electrophysiology portfolio by incorporating Affera’s innovative Tacticath system and advancing its cardiac catheter technology capabilities. Affera Inc., based in the U.S., develops medical devices focused on treating heart rhythm disorders, with a specialization in cryoablation devices.

Major companies operating in the cryoablation devices market are Medtronic plc, Siemens Healthineers AG, GE Healthcare, Boston Scientific Corporation, Varian Medical Systems Inc., CooperSurgical Inc., MicroPort Scientific Corporation, PENTAX Medical, AtriCure Inc., Vimecon GmbH, Erbe Elektromedizin GmbH, MedGyn Products Inc., HealthTronics Inc., METRUM CRYOFLEX Sp. z o.o., BVM Medical Limited., Adagio Medical Inc., Channel Medsystems Inc., CPSI Biotech, CryoTherapeutics GmbH, Endocare Inc., Galil Medical Ltd., Sanarus Technologies Inc., IceCure Medical Ltd.

North America was the largest region in the cryoablation devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cryoablation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cryoablation devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Cryoablation devices are specialized medical tools utilized for cryoablation procedures, which involve using extreme cold to eliminate abnormal tissues such as tumors or malfunctioning heart tissue. These devices are pivotal in modern medicine, offering a minimally invasive method for treating specific medical conditions by freezing targeted tissues under controlled conditions.

There are several types of cryoablation devices, including probes, tissue contact probe ablators, epidermal and subcutaneous cryoablation systems, generators, and associated accessories and consumables. The design and configuration of the cryoablation probe, categorized by probe type, are crucial in enhancing the effectiveness, safety, and precision of cryoablation procedures across various medical disciplines. Cryoablation finds applications in cardiology, oncology, and other medical fields, serving diverse end-users such as hospitals, ambulatory surgical centers, and specialty clinics.

The cryoablation devices market research report is one of a series of new reports that provides cryoablation devices market statistics, including cryoablation devices industry global market size, regional shares, competitors with a cryoablation devices market share, detailed cryoablation devices market segments, market trends, and opportunities, and any further data you may need to thrive in the cryoablation devices industry. This cryoablation devices research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The cryoablation devices market consists of sales general cryoprobes, cryogen delivery systems, cryoablation consoles, imaging guidance systems, and portable cryoablation systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.